Delivery Order SPE2DB20D2104-SPE2DB24FV70F

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,502.14 firm fixed-price delivery order is for the supply of ISOSULFAN BLUE 1% VIAL 5ML, with a completion date of August 7, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,371.77 firm-fixed-price delivery order is for the supply of Isosulfan Blue 1% Vial 5mL, a medical product used in various medical procedures. The contract has an ultimate completion date of October 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Isosulfan Blue 1% Vial 5ML, a medical product used for various purposes. The contract has a ceiling value of $13,663.39 and runs through December 19, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,118.25, is for the delivery of 5 mL vials of 1% Isosulfan Blue, a medical product used in healthcare settings. The contract has a firm fixed price and an ultimate completion date of January 13, 2025. It is a delivery order, with no set-aside designation, indicating open competition....
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific award is for the procurement...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,209.74 firm fixed-price delivery order is for the supply of 5ml vials of 1% Isosulfan Blue, with a completion date of February 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Isosulfan Blue 1% Vial 5ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $13,047.60 and a period of performance through January 17, 2025. The contract does not have a set-aside designation, indicating it was open to full and open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FM1L0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,942.15 firm-fixed-price delivery order is for the supply of 4555811271 - ISOSULFAN BLUE 1% VIAL 5ML. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) has awarded a delivery order contract worth $39,170.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,450,073 units of 1% Isosulfan Blue Vial (5 mL). This contract has a firm fixed price and an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is a major pharmaceutical supplier to the U.S. federal government, particularly the Department of Defense (DoD) and...
This is a $2,174.59 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a medical product, with a completion date of June 28, 2022. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV70F
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,356.52, is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML, a medical supply product. The contract has a firm fixed price and an ultimate completion date of August 15, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 9:54 AM